Onera Health is a technology company.
Onera Health has raised $33.0M across 1 funding round.
Onera Health has raised $33.0M in total across 1 funding round.
Onera Health has raised $33.0M in total across 1 funding round.
Onera Health's investors include Atlantic Bridge, EQT Life Sciences.
Onera Health is a MedTech company developing the Onera Sleep Test System (STS), a clinical-grade, patch-based polysomnography (PSG) solution that enables wireless, at-home sleep diagnostics.[1][2][7] It serves clinicians, sleep labs, and patients by capturing key physiological signals like EEG, ECG, respiratory effort, oxygen levels, and more, solving the problem of cumbersome, hospital-bound sleep testing that limits access and increases costs.[1][4][7] The PSG-as-a-Service model combines hardware with a cloud platform for easy setup, data analysis, and reporting, with CE mark and FDA 510(k) clearance, driving growth through expansions like Japan in 2025.[2][4]
Founded in 2017 as a spin-off from imec, a leading nanoelectronics research center, Onera Health emerged from innovations in biomedical sensors and digital health technologies in Eindhoven, Netherlands.[3][9] Ruben de Francisco, the Founder and CEO, led the development of miniaturized, low-power chips for wearable diagnostics, starting with sleep monitoring.[3] Early traction came from the Onera STS, which simplified PSG from wired lab setups to self-applied patches, gaining regulatory approvals and investor backing from firms like Innovation Industries and Gimv.[2][5]
Onera rides the wave of remote diagnostics and wearable MedTech, addressing a global sleep disorder crisis affecting millions, with high prevalence in aging populations like Japan.[2][4] Timing aligns with post-pandemic demand for home-based care, easing hospital pressures amid clinician shortages and rising chronic conditions.[4] Market forces favor it: regulatory clearances boost adoption, while Brabant region's ecosystem—High Tech Campus Eindhoven, TU/e—fuels medtech innovation alongside peers like MedEye.[4][9] Onera influences the ecosystem by democratizing PSG, optimizing patient care, and expanding sensor tech to wellness and fitness.[3][6]
Onera is poised for scaled global adoption, building on Japan entry and chip tech for multi-disease monitoring in sleep, neuro, and cardiac fields.[3][4] Trends like AI-driven analysis, telehealth integration, and miniaturized wearables will accelerate growth, potentially capturing share in a $10B+ sleep diagnostics market. Its influence may evolve from sleep specialist to platform provider, partnering with health systems for anytime-anywhere PSG, ultimately transforming access for underserved patients worldwide—echoing its mission to bring hospital-grade care home.[2][7]
Onera Health has raised $33.0M across 1 funding round. Most recently, it raised $33.0M Series C in January 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2024 | $33.0M Series C | Atlantic Bridge, EQT Life Sciences |